These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 17245735)

  • 1. Inflammatory markers of lung disease in adult patients with cystic fibrosis.
    Levy H; Kalish LA; Huntington I; Weller N; Gerard C; Silverman EK; Celedón JC; Pier GB; Weiss ST
    Pediatr Pulmonol; 2007 Mar; 42(3):256-62. PubMed ID: 17245735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum KL-6 as a novel disease marker in adolescent and adult cystic fibrosis.
    Ohshimo S; Bonella F; Grammann N; Starke K; Cui A; Bauer PC; Teschler H; Kohno N; Guzman J; Costabel U
    Sarcoidosis Vasc Diffuse Lung Dis; 2009 Jul; 26(1):47-53. PubMed ID: 19960788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine gene polymorphisms and severity of CF lung disease.
    de Vries L; Griffiths A; Armstrong D; Robinson PJ
    J Cyst Fibros; 2014 Dec; 13(6):699-705. PubMed ID: 24853301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of common haplotypes of surfactant protein A1 and A2 (SFTPA1 and SFTPA2) genes with severity of lung disease in cystic fibrosis.
    Choi EH; Ehrmantraut M; Foster CB; Moss J; Chanock SJ
    Pediatr Pulmonol; 2006 Mar; 41(3):255-62. PubMed ID: 16429424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart involvement in children and adults with cystic fibrosis: correlation with pulmonary indexes and inflammation markers.
    Giacchi V; Rotolo N; Amato B; Di Dio G; Betta P; La Rosa M; Leonardi S; Sciacca P
    Heart Lung Circ; 2015 Oct; 24(10):1002-10. PubMed ID: 25911142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung disease severity, chronic inflammation, iron deficiency, and erythropoietin response in adults with cystic fibrosis.
    Fischer R; Simmerlein R; Huber RM; Schiffl H; Lang SM
    Pediatr Pulmonol; 2007 Dec; 42(12):1193-7. PubMed ID: 17948283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha1-antitrypsin deficiency alleles and the Taq-I G-->A allele in cystic fibrosis lung disease.
    Mahadeva R; Westerbeek RC; Perry DJ; Lovegrove JU; Whitehouse DB; Carroll NR; Ross-Russell RI; Webb AK; Bilton D; Lomas DA
    Eur Respir J; 1998 Apr; 11(4):873-9. PubMed ID: 9623690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change in C-reactive protein levels and FEV1 decline: a longitudinal population-based study.
    Shaaban R; Kony S; Driss F; Leynaert B; Soussan D; Pin I; Neukirch F; Zureik M
    Respir Med; 2006 Dec; 100(12):2112-20. PubMed ID: 16650972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of improved pulmonary phenotype in Irish cystic fibrosis patients with a 3' enhancer polymorphism in alpha-1-antitrypsin.
    Courtney JM; Plant BJ; Morgan K; Rendall J; Gallagher C; Ennis M; Kalsheker N; Elborn S; O'Connor CM
    Pediatr Pulmonol; 2006 Jun; 41(6):584-91. PubMed ID: 16617455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of nutritional status, plasma, albumin levels and pulmonary function in cystic fibrosis.
    Souza dos Santos Simon MI; Drehmer M; de Abreu E Silva FA; Hoffmann A; Druck Ricachinewsky C; de Fonseca Andrade Procianoy E; Scattolin I; Saldanha Menna Barreto S
    Nutr Hosp; 2011; 26(6):1322-7. PubMed ID: 22411378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis.
    Sagel SD; Kapsner RK; Osberg I
    Pediatr Pulmonol; 2005 Mar; 39(3):224-32. PubMed ID: 15635615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of IgG antibodies to Exophiala dermatitidis is associated with inflammatory responses in patients with cystic fibrosis.
    Kondori N; Lindblad A; Welinder-Olsson C; Wennerås C; Gilljam M
    J Cyst Fibros; 2014 Jul; 13(4):391-9. PubMed ID: 24439251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of treatment of cystic fibrosis pulmonary exacerbations on systemic inflammation.
    Sagel SD; Thompson V; Chmiel JF; Montgomery GS; Nasr SZ; Perkett E; Saavedra MT; Slovis B; Anthony MM; Emmett P; Heltshe SL
    Ann Am Thorac Soc; 2015 May; 12(5):708-17. PubMed ID: 25714657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility of C-reactive protein to predict treatment response during cystic fibrosis pulmonary exacerbations.
    Sharma A; Kirkpatrick G; Chen V; Skolnik K; Hollander Z; Wilcox P; Quon BS
    PLoS One; 2017; 12(2):e0171229. PubMed ID: 28178305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum retinol levels and pulmonary function in children and adolescents with cystic fibrosis.
    Woestenenk JW; Broos N; Stellato RK; Arets HG; van der Ent CK; Houwen RH
    J Cyst Fibros; 2015 May; 14(3):392-7. PubMed ID: 25595045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inverse relation between vitamin D and serum total immunoglobulin G in the Scandinavian Cystic Fibrosis Nutritional Study.
    Pincikova T; Nilsson K; Moen IE; Karpati F; Fluge G; Hollsing A; Knudsen PK; Lindblad A; Mared L; Pressler T; Hjelte L;
    Eur J Clin Nutr; 2011 Jan; 65(1):102-9. PubMed ID: 20859300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-sectional associations of pulmonary function with systemic inflammation and oxidative stress in individuals with chronic spinal cord injury.
    Hart JE; Morse L; Tun CG; Brown R; Garshick E
    J Spinal Cord Med; 2016 May; 39(3):344-52. PubMed ID: 26180939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary function disparities exist and persist in Hispanic patients with cystic fibrosis: A longitudinal analysis.
    McGarry ME; Neuhaus JM; Nielson DW; Burchard E; Ly NP
    Pediatr Pulmonol; 2017 Dec; 52(12):1550-1557. PubMed ID: 29082671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic inflammatory markers in relation to lung function in NHANES. 2007-2010.
    Nerpin E; Jacinto T; Fonseca JA; Alving K; Janson C; Malinovschi A
    Respir Med; 2018 Sep; 142():94-100. PubMed ID: 30170809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extending the course of intravenous antibiotics in adult patients with cystic fibrosis with acute pulmonary exacerbations.
    Sequeiros IM; Jarad NA
    Chron Respir Dis; 2012; 9(4):213-20. PubMed ID: 22637747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.